These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36614035)

  • 1. HMGA1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in Breast Cancer Cells.
    Petrosino S; Pacor S; Pegoraro S; Gazziero VA; Canarutto G; Piazza S; Manfioletti G; Sgarra R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
    Sgubin M; Pegoraro S; Pellarin I; Ros G; Sgarra R; Piazza S; Baldassarre G; Belletti B; Manfioletti G
    Cell Death Dis; 2022 May; 13(5):429. PubMed ID: 35504904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
    Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
    PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.
    Tolza C; Bejjani F; Evanno E; Mahfoud S; Moquet-Torcy G; Gostan T; Maqbool MA; Kirsh O; Piechaczyk M; Jariel-Encontre I
    Mol Cancer Res; 2019 Oct; 17(10):1999-2014. PubMed ID: 31300541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
    Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
    Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer.
    Fiscon G; Pegoraro S; Conte F; Manfioletti G; Paci P
    FEBS Lett; 2021 Jun; 595(11):1569-1586. PubMed ID: 33835503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
    Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
    Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
    Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
    Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
    Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
    BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
    Brocher J; Vogel B; Hock R
    BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
    Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
    Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
    Pujals M; Resar L; Villanueva J
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
    Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
    Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
    Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
    Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group A1 and cancer: potential biomarker and therapeutic target.
    Shah SN; Resar LM
    Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mobility group protein HMGA1 inhibits retinoblastoma protein-mediated cellular G0 arrest.
    Ueda Y; Watanabe S; Tei S; Saitoh N; Kuratsu J; Nakao M
    Cancer Sci; 2007 Dec; 98(12):1893-901. PubMed ID: 17877762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair.
    Pellarin I; Arnoldo L; Costantini S; Pegoraro S; Ros G; Penzo C; Triolo G; Demarchi F; Sgarra R; Vindigni A; Manfioletti G
    PLoS One; 2016; 11(10):e0164258. PubMed ID: 27723831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.